Holen Sie sich die Stockscreener-App
0.9361
0.48%
0.0045
Vorhandelsmarkt:
.96
0.0239
+2.55%
Schlusskurs vom Vortag:
$0.9316
Offen:
$0.98
24-Stunden-Volumen:
1.09M
Relative Volume:
0.65
Marktkapitalisierung:
$89.69M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-93.61M
KGV:
-0.4436
EPS:
-2.11
Netto-Cashflow:
$-71.16M
1W Leistung:
+12.36%
1M Leistung:
+30.01%
6M Leistung:
-4.83%
1J Leistung:
-35.88%
1-Tages-Spanne:
$0.9334
$0.99
1-Wochen-Bereich:
$0.8357
$1.035
52-Wochen-Spanne:
$0.561
$2.11
Immunic Inc Stock (IMUX) Company Profile
Firmenname
Immunic Inc
Sektor
Branche
Telefon
(332) 255-9818
Adresse
1200 AVENUE OF THE AMERICAS, NEW YORK
Vergleichen Sie IMUX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMUX
Immunic Inc
|
0.9361 | 79.83M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-25 | Eingeleitet | William Blair | Outperform |
| 2024-11-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2024-08-27 | Eingeleitet | B. Riley Securities | Buy |
| 2022-10-21 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-04-15 | Eingeleitet | Aegis Capital | Buy |
| 2021-03-24 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-02 | Eingeleitet | SVB Leerink | Outperform |
| 2020-08-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-07 | Fortgesetzt | ROTH Capital | Buy |
| 2020-07-20 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-06-05 | Eingeleitet | Wedbush | Outperform |
| 2020-05-11 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-03-25 | Eingeleitet | ROTH Capital | Buy |
| 2019-07-11 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Immunic Inc Aktie (IMUX) Neueste Nachrichten
Immunic Inc. Stock Analysis and ForecastHigh-yield investments - jammulinksnews.com
Is Immunic Inc. a good long term investmentHigh-yield capital appreciation - jammulinksnews.com
What analysts say about Immunic Inc. stockFastest return on investment - jammulinksnews.com
World Brain Day: Immunic targets MS with new therapy - Proactive financial news
What drives Immunic Inc. stock priceOutstanding risk-reward balance - jammulinksnews.com
IMUX’s Stock Market Puzzle: Piecing Together 2025’s Performance - investchronicle.com
What makes Immunic Inc. stock price move sharplyValue Pick Scanner - Newser
How Immunic Inc. stock performs during market volatilityFree Top Growth Stock Recommendations - Newser
Why Immunic Inc. stock attracts strong analyst attentionFree Capital Allocation Plans - Newser
Immunic board authorizes up to 35 million stock appreciation rights for employees By Investing.com - Investing.com South Africa
Immunic board authorizes up to 35 million stock appreciation rights for employees - Investing.com Australia
KULR Technology Group Announces $20 Million Credit Facility with Coinbase - Stocktwits
Immunic, Inc. Announces Proposed Public Offering - NewsBreak: Local News & Alerts
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering - NewsBreak: Local News & Alerts
Immunic to Participate in Scientific and Industry Conferences in May - NewsBreak: Local News & Alerts
Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial By Stocktwits - Investing.com India
Immunic, Inc. Announces Proposed Public Offering By Stocktwits - Investing.com India
Immunic, Inc. Announces Pricing of Oversubscribed $65 Million Underwritten Public Offering By Stocktwits - Investing.com India
Immunic to Participate in Scientific and Industry Conferences in May By Stocktwits - Investing.com India
Immunic, Inc. (NASDAQ:IMUX) Given Consensus Rating of “Buy” by Brokerages - Defense World
Immunic to Participate in Investor, Scientific and Industry Conferences in June - MSN
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering - NewsBreak: Local News & Alerts
Immunic Announces Completion of Enrollment for Both Phase 3 ENSURE Trials in Relapsing MS and Presents Additional Data Underlining Positive Outcome of Phase 2 CALLIPER Trial in Progressive MS By Stocktwits - Investing.com India
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis By Stocktwits - Investing.com India
Immunic to Participate in Investor, Scientific and Industry Conferences in June By Stocktwits - Investing.com India
Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering By Stocktwits - Investing.com India
Immunic CEO discusses Phase 2 multiple sclerosis study successICYMI - Proactive Investors
Immunic reveals MS drug trial success - Proactive Investors
Immunic reveals MS drug trial success | NASDAQ:IMUX - Proactive Investors
Immunic reports low disability worsening rates in MS drug trial By Investing.com - Investing.com Nigeria
Immunic reveals long-term data supporting potential of MS drug vidofludimus calcium - Proactive financial news
Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis - Stocktwits
Immunic highlights MS treatment progression at BIO International Convention in Boston - Proactive Investors
Financial Metrics Check: Immunic Inc (IMUX)’s Ratios for Trailing Twelve Months - DWinneX
Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of “Buy” by Brokerages - Defense World
Immunic Post-Readout: Reiterating Strong Buy As Big Drop Appears Unwarranted (NASDAQ:IMUX) - Seeking Alpha
Millennium Management LLC Has $580,000 Stake in Immunic, Inc. (NASDAQ:IMUX) - Defense World
Immunic completes Phase 3 multiple sclerosis trial enrollmentICYMI - Proactive financial news
Finanzdaten der Immunic Inc-Aktie (IMUX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Immunic Inc-Aktie (IMUX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Tardio Jason | President and COO |
Jun 05 '25 |
Buy |
0.79 |
12,512 |
9,884 |
12,512 |
| Vitt Daniel | CEO and Director |
Jun 04 '25 |
Buy |
0.77 |
15,000 |
11,550 |
29,000 |
| Neermann Joerg | Director |
Jun 04 '25 |
Buy |
0.77 |
70,000 |
53,900 |
170,000 |
| Neermann Joerg | Director |
Jun 05 '25 |
Buy |
0.76 |
30,000 |
22,800 |
200,000 |
| Whaley Glenn | Chief Financial Officer |
Jun 03 '25 |
Buy |
0.71 |
45,000 |
32,076 |
95,510 |
| Rudick Richard Alan | Director |
Jun 03 '25 |
Buy |
0.70 |
143,075 |
100,024 |
230,375 |
| Rudick Richard Alan | Director |
Nov 12 '24 |
Buy |
1.15 |
87,300 |
100,369 |
87,300 |
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):